Help Us Combat Abortion Stigma In Primary Care Today!
Written by Jessica Beaman, MD MPH The National Abortion Federation (NAF) recently updated its guidelines, removing Rh testing and Rhogam treatment for people seeking medication and surgical abortion care with gestation under 12 weeks.¹ This update aligns with the current World Health Organization guidelines and has the potential to reduce barriers to care.² Previous NAF…
Written by Stephanie Mischell The current legal landscape of abortion care is varied and hostile. As more states ban or restrict abortion access, patients are facing more stigma and misinformation when navigating abortion care than ever. As clinicians, it is our duty to advocate for patients by providing nonjudgmental and compassionate options counseling, and accurate…
Self-managed/self-sourced medication abortion (SMA) with mifepristone and misoprostol or misoprostol alone is safe and effective. It can be empowering and life-saving.1,2 As abortion restrictions and bans spread across the US, primary care clinicians and other health professionals will encounter more patients who are interested in using or have used these medications on their own. Most…
Guidance on initiating progestin injection or progestin implant after a medication abortion.
This issue summarized the key equipment and supplies needed to provide manual vacuum aspiration in an outpatient setting.
This issue outlines the use of low-sensitivity pregnancy tests in managing medication abortion.
This issue addresses the use ultrasounds in managing medication abortion.
This issue covers best practices for using local anesthesia to decrease pain associated with uterine aspiration.
This issue covers the three clinical strategies available for managing pain associated with uterine aspiration.
This issue reviews the clinical evidence for treating Rh negative patients who have a first trimester pregnancy loss or abortion.
Your gift allows us to mobilize, train, and support clinicians across the country to provide reproductive health care.